TreeWAS – Variant ID: rs10486158

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T46 Poisoning by agents primarily affecting the cardiovascular system	0.029	0.971	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.029	0.971	0.000
N35.9 Urethral stricture, unspecified	0.000	0.972	0.028
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.028	0.972	0.000
N93.9 Abnormal uterine and vaginal bleeding, unspecified	0.027	0.973	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.027	0.973	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.027	0.973	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.026	0.974	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.026	0.974	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.025	0.974	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.025	0.975	0.000
T43.2 Other and unspecified antidepressants	0.024	0.976	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.024	0.976	0.000
T46.1 Calcium-channel blockers	0.024	0.976	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.024	0.976	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.024	0.976	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.024	0.976	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.023	0.977	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.023	0.977	0.000
T43.6 Psychostimulants with abuse potential	0.023	0.977	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.023	0.977	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.023	0.977	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.022	0.977	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.022	0.978	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.022	0.978	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.022	0.978	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.022	0.978	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.022	0.978	0.000
T42.3 Barbiturates	0.022	0.978	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.021	0.979	0.000
T46.7 Peripheral vasodilators	0.021	0.979	0.000
T42.1 Iminostilbenes	0.021	0.979	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.021	0.979	0.000
T38.1 Thyroid hormones and substitutes	0.021	0.979	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.021	0.979	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.021	0.979	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.020	0.980	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.020	0.980	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.020	0.980	0.000
T42.4 Benzodiazepines	0.020	0.980	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.020	0.980	0.000
T38.5 Other oestrogens and progestogens	0.020	0.980	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.020	0.980	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.020	0.980	0.000
T42.2 Succinimides and oxazolidinediones	0.020	0.980	0.000
T38.9 Other and unspecified hormone antagonists	0.019	0.980	0.000
T38.7 Androgens and anabolic congeners	0.019	0.980	0.000
T38.4 Oral contraceptives	0.019	0.980	0.000
T38.2 Antithyroid drugs	0.019	0.980	0.000
T43.9 Psychotropic drug, unspecified	0.019	0.980	0.000
T38.0 Glucocorticoids and synthetic analogues	0.019	0.980	0.000
T45.2 Vitamins, not elsewhere classified	0.019	0.981	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.019	0.981	0.000
T42.0 Hydantoin derivatives	0.019	0.981	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.019	0.981	0.000
T45.0 Antiallergic and antiemetic drugs	0.019	0.981	0.000
T50.7 Analeptics and opioid receptor antagonists	0.018	0.981	0.000
T50.5 Appetite depressants	0.018	0.981	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.018	0.981	0.000
T50.0 Mineralocorticoids and their antagonists	0.018	0.981	0.000
T50.1 Loop [high-ceiling] diuretics	0.018	0.982	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.018	0.982	0.000
T36 Poisoning by systemic antibiotics	0.018	0.982	0.000
T45.4 Iron and its compounds	0.018	0.982	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.018	0.982	0.000
T41.2 Other and unspecified general anaesthetics	0.018	0.982	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.017	0.982	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.017	0.982	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.017	0.982	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.017	0.982	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.017	0.982	0.000
T44.0 Anticholinesterase agents	0.017	0.982	0.000
T50.4 Drugs affecting uric acid metabolism	0.017	0.983	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.983	0.017
T45.9 Primarily systemic and haematological agent, unspecified	0.016	0.983	0.000
T45.8 Other primarily systemic and haematological agents	0.016	0.983	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.016	0.983	0.000
T45.6 Fibrinolysis-affecting drugs	0.016	0.983	0.000
T45.3 Enzymes, not elsewhere classified	0.016	0.983	0.000
T41.5 Therapeutic gases	0.016	0.984	0.000
T41.4 Anaesthetic, unspecified	0.016	0.984	0.000
T41.3 Local anaesthetics	0.016	0.984	0.000
T41.1 Intravenous anaesthetics	0.016	0.984	0.000
T41.0 Inhaled anaesthetics	0.016	0.984	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.016	0.984	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.016	0.984	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.016	0.984	0.000
T49.9 Topical agent, unspecified	0.016	0.984	0.000
T49.8 Other topical agents	0.016	0.984	0.000
T49.7 Dental drugs, topically applied	0.016	0.984	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.016	0.984	0.000
T49.5 Ophthalmological drugs and preparations	0.016	0.984	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.016	0.984	0.000
T49.3 Emollients, demulcents and protectants	0.016	0.984	0.000
T49.2 Local astringents and local detergents	0.016	0.984	0.000
T49.1 Antipruritics	0.016	0.984	0.000
T45.5 Anticoagulants	0.015	0.985	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.015	0.985	0.000
T48.5 Anti-common-cold drugs	0.015	0.985	0.000
T47.2 Stimulant laxatives	0.015	0.985	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.015	0.985	0.000
T37.5 Antiviral drugs	0.015	0.985	0.000
T37.4 Anthelminthics	0.015	0.985	0.000
T37.3 Other antiprotozoal drugs	0.015	0.985	0.000
T37.1 Antimycobacterial drugs	0.015	0.985	0.000
T37.0 Sulphonamides	0.015	0.985	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.015	0.985	0.000
T48.4 Expectorants	0.015	0.985	0.000
T48.3 Antitussives	0.015	0.985	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.015	0.985	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.015	0.985	0.000
T48.0 Oxytocic drugs	0.015	0.985	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.015	0.985	0.000
T47.0 Histamine H(2)-receptor antagonists	0.014	0.985	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.014	0.986	0.000
T50.8 Diagnostic agents	0.014	0.986	0.000
N35 Urethral stricture	0.000	0.986	0.014
T47.6 Antidiarrhoeal drugs	0.014	0.986	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.014	0.986	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.014	0.986	0.000
T47.7 Emetics	0.014	0.986	0.000
T47.5 Digestants	0.014	0.986	0.000
T47.3 Saline and osmotic laxatives	0.014	0.986	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.014	0.986	0.000
N32.3 Diverticulum of bladder	0.000	0.986	0.014
T36.4 Tetracyclines	0.013	0.986	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.013	0.986	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.013	0.987	0.000
T36.9 Systemic antibiotic, unspecified	0.013	0.987	0.000
T36.7 Antifungal antibiotics, systemically used	0.013	0.987	0.000
T36.6 Rifamycins	0.013	0.987	0.000
T36.5 Aminoglycosides	0.013	0.987	0.000
T36.2 Chloramphenicol group	0.013	0.987	0.000
T36.8 Other systemic antibiotics	0.013	0.987	0.000
N13 Obstructive and reflux uropathy	0.000	0.987	0.013
T40.3 Methadone	0.013	0.987	0.000
T40.1 Heroin	0.013	0.987	0.000
N13.9 Obstructive and reflux uropathy, unspecified	0.000	0.987	0.013
T47.4 Other laxatives	0.013	0.987	0.000
T36.0 Penicillins	0.012	0.987	0.000
T40.5 Cocaine	0.012	0.987	0.000
Q61.3 Polycystic kidney, unspecified	0.000	0.988	0.012
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.012	0.988	0.000
Q61 Cystic kidney disease	0.000	0.988	0.012
N13.6 Pyonephrosis	0.000	0.988	0.012
T36.3 Macrolides	0.012	0.988	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.012	0.988	0.000
T40.8 Lysergide [LSD]	0.012	0.988	0.000
T40.7 Cannabis (derivatives)	0.012	0.988	0.000
T40.0 Opium	0.012	0.988	0.000
N13.5 Kinking and stricture of ureter without hydronephrosis	0.000	0.988	0.012
Q61.0 Congenital single renal cyst	0.000	0.988	0.012
T40.6 Other and unspecified narcotics	0.011	0.989	0.000
N93 Other abnormal uterine and vaginal bleeding	0.011	0.989	0.000
N13.7 Vesicoureteral-reflux-associated uropathy	0.000	0.989	0.011
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.989	0.011
Q61.4 Renal dysplasia	0.000	0.989	0.011
N10-N16 Renal tubulo-interstitial diseases	0.000	0.989	0.011
N32 Other disorders of bladder	0.000	0.989	0.011
T47.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
N35.0 Posttraumatic urethral stricture	0.000	0.990	0.010
N12 Tubulo-interstitial nephritis, not specified as acute or chronic	0.000	0.990	0.010
N10 Acute tubulo-interstitial nephritis	0.000	0.990	0.010
N32.8 Other specified disorders of bladder	0.000	0.990	0.010
N35.1 Postinfective urethral stricture, not elsewhere classified	0.000	0.990	0.010
N13.0 Hydronephrosis with ureteropelvic junction obstruction	0.000	0.990	0.010
Q60-Q64 Congenital malformations of the urinary system	0.000	0.990	0.010
Q61.2 Polycystic kidney, adult type	0.000	0.990	0.010
T45.1 Antineoplastic and immunosuppressive drugs	0.009	0.990	0.001
N13.4 Hydroureter	0.000	0.990	0.009
Q60 Renal agenesis and other reduction defects of kidney	0.000	0.991	0.009
Q61.8 Other cystic kidney diseases	0.000	0.991	0.009
Q61.1 Polycystic kidney, infantile type	0.000	0.991	0.009
N13.2 Hydronephrosis with renal and ureteral calculous obstruction	0.000	0.991	0.009
N36.8 Other specified disorders of urethra	0.000	0.991	0.009
N93.0 Postcoital and contact bleeding	0.009	0.991	0.000
T40.4 Other synthetic narcotics	0.008	0.991	0.000
Q63 Other congenital malformations of kidney	0.000	0.991	0.009
R52.2 Other chronic pain	0.009	0.991	0.000
N30-N39 Other diseases of urinary system	0.000	0.991	0.009
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.008	0.991	0.000
N13.8 Other obstructive and reflux uropathy	0.000	0.992	0.008
N32.0 Bladder-neck obstruction	0.000	0.992	0.008
N32.1 Vesicointestinal fistula	0.000	0.992	0.008
Q61.9 Cystic kidney disease, unspecified	0.000	0.992	0.008
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.992	0.008
Q63.0 Accessory kidney	0.000	0.992	0.008
N14 Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions	0.000	0.992	0.008
Q60.3 Renal hypoplasia, unilateral	0.000	0.992	0.008
Q60.2 Renal agenesis, unspecified	0.000	0.992	0.008
N36 Other disorders of urethra	0.000	0.992	0.008
N32.4 Rupture of bladder, nontraumatic	0.000	0.992	0.008
N15 Other renal tubulo-interstitial diseases	0.000	0.992	0.008
N35.8 Other urethral stricture	0.000	0.992	0.008
N93.8 Other specified abnormal uterine and vaginal bleeding	0.008	0.992	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.008	0.992	0.000
J36 Peritonsillar abscess	0.000	0.992	0.008
N11 Chronic tubulo-interstitial nephritis	0.000	0.992	0.007
Q60.0 Renal agenesis, unilateral	0.000	0.993	0.007
N16 Renal tubulo-interstitial disorders in diseases classified elsewhere	0.000	0.993	0.007
Q61.5 Medullary cystic kidney	0.000	0.993	0.007
N13.3 Other and unspecified hydronephrosis	0.000	0.993	0.007
Q60.6 Potter's syndrome	0.000	0.993	0.007
Q60.5 Renal hypoplasia, unspecified	0.000	0.993	0.007
Q60.4 Renal hypoplasia, bilateral	0.000	0.993	0.007
Q60.1 Renal agenesis, bilateral	0.000	0.993	0.007
N32.2 Vesical fistula, not elsewhere classified	0.000	0.993	0.007
T39.0 Salicylates	0.007	0.993	0.000
Q64 Other congenital malformations of urinary system	0.000	0.993	0.007
Q63.8 Other specified congenital malformations of kidney	0.000	0.993	0.007
Q62.2 Congenital megaloureter	0.000	0.993	0.006
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.993	0.006
Q63.3 Hyperplastic and giant kidney	0.000	0.994	0.006
N37 Urethral disorders in diseases classified elsewhere	0.000	0.994	0.006
N33 Bladder disorders in diseases classified elsewhere	0.000	0.994	0.006
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.006	0.994	0.000
T39.4 Antirheumatics, not elsewhere classified	0.006	0.994	0.000
T39.2 Pyrazolone derivatives	0.006	0.994	0.000
R52.1 Chronic intractable pain	0.006	0.994	0.000
Q62.5 Duplication of ureter	0.000	0.994	0.006
N34 Urethritis and urethral syndrome	0.000	0.994	0.006
Q63.2 Ectopic kidney	0.000	0.994	0.006
Q62.1 Atresia and stenosis of ureter	0.000	0.994	0.006
N71 Inflammatory disease of uterus, except cervix	0.000	0.994	0.006
N14.4 Toxic nephropathy, not elsewhere classified	0.000	0.994	0.006
N14.3 Nephropathy induced by heavy metals	0.000	0.994	0.006
N14.2 Nephropathy induced by unspecified drug, medicament or biological substance	0.000	0.994	0.006
N14.0 Analgesic nephropathy	0.000	0.994	0.006
Q62.8 Other congenital malformations of ureter	0.000	0.994	0.006
Q62.7 Congenital vesico-uretero-renal reflux	0.000	0.994	0.006
Q62.6 Malposition of ureter	0.000	0.994	0.006
Q62.4 Agenesis of ureter	0.000	0.994	0.006
Q62.0 Congenital hydronephrosis	0.000	0.994	0.006
N36.0 Urethral fistula	0.000	0.994	0.006
N14.1 Nephropathy induced by other drugs, medicaments and biological substances	0.000	0.994	0.006
N15.8 Other specified renal tubulo-interstitial diseases	0.000	0.994	0.006
N15.0 Balkan nephropathy	0.000	0.994	0.006
N36.2 Urethral caruncle	0.000	0.994	0.006
N11.9 Chronic tubulo-interstitial nephritis, unspecified	0.000	0.994	0.006
N15.9 Renal tubulo-interstitial disease, unspecified	0.000	0.994	0.006
N15.1 Renal and perinephric abscess	0.000	0.994	0.006
N36.1 Urethral diverticulum	0.000	0.994	0.006
N11.8 Other chronic tubulo-interstitial nephritis	0.000	0.994	0.005
Q62.3 Other obstructive defects of renal pelvis and ureter	0.000	0.994	0.005
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.994	0.005
N16.8 Renal tubulo-interstitial disorders in other diseases classified elsewhere	0.000	0.994	0.005
N16.4 Renal tubulo-interstitial disorders in systemic connective tissue disorders	0.000	0.994	0.005
N16.3 Renal tubulo-interstitial disorders in metabolic diseases	0.000	0.994	0.005
N16.2 Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism	0.000	0.994	0.005
N16.1 Renal tubulo-interstitial disorders in neoplastic diseases	0.000	0.994	0.005
N34.2 Other urethritis	0.000	0.994	0.006
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.005	0.994	0.000
R52 Pain, not elsewhere classified	0.006	0.994	0.000
N16.0 Renal tubulo-interstitial disorders in infectious and parasitic diseases classified elsewhere	0.000	0.994	0.005
N36.9 Urethral disorder, unspecified	0.000	0.994	0.005
N18.0 End-stage renal disease	0.000	0.995	0.005
N11.0 Nonobstructive reflux-associated chronic pyelonephritis	0.000	0.995	0.005
J31.0 Chronic rhinitis	0.005	0.995	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.000	0.995	0.005
Q64.8 Other specified congenital malformations of urinary system	0.000	0.995	0.005
Q64.6 Congenital diverticulum of bladder	0.000	0.995	0.005
Q64.5 Congenital absence of bladder and urethra	0.000	0.995	0.005
Q64.2 Congenital posterior urethral valves	0.000	0.995	0.005
Q64.1 Exstrophy of urinary bladder	0.000	0.995	0.005
Q64.0 Epispadias	0.000	0.995	0.005
N16.5 Renal tubulo-interstitial disorders in transplant rejection	0.000	0.995	0.005
N11.1 Chronic obstructive pyelonephritis	0.000	0.995	0.005
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.995	0.005
E66.8 Other obesity	0.005	0.995	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.000	0.995	0.005
N33.0 Tuberculous cystitis	0.000	0.995	0.005
N37.8 Other urethral disorders in diseases classified elsewhere	0.000	0.995	0.005
N37.0 Urethritis in diseases classified elsewhere	0.000	0.995	0.005
T40.2 Other opioids	0.005	0.995	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.000	0.995	0.005
Q64.4 Malformation of urachus	0.000	0.995	0.005
N34.0 Urethral abscess	0.000	0.995	0.005
N71.0 Acute inflammatory disease of uterus	0.000	0.995	0.005
N36.3 Prolapsed urethral mucosa	0.000	0.996	0.004
B44.1 Other pulmonary aspergillosis	0.004	0.996	0.000
N34.3 Urethral syndrome, unspecified	0.000	0.996	0.004
N34.1 Nonspecific urethritis	0.000	0.996	0.004
I72.3 Aneurysm of iliac artery	0.000	0.996	0.004
C71.9 Brain, unspecified	0.004	0.996	0.000
Z63.4 Disappearance and death of family member	0.004	0.996	0.000
H43.3 Other vitreous opacities	0.000	0.996	0.004
R52.9 Pain, unspecified	0.004	0.996	0.000
N71.1 Chronic inflammatory disease of uterus	0.000	0.996	0.004
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.000	0.996	0.004
M72.2 Plantar fascial fibromatosis	0.004	0.996	0.000
N30 Cystitis	0.000	0.996	0.004
I60.9 Subarachnoid haemorrhage, unspecified	0.004	0.996	0.000
C71 Malignant neoplasm of brain	0.004	0.996	0.000
N43.3 Hydrocele, unspecified	0.000	0.997	0.003
Z63 Other problems related to primary support group, including family circumstances	0.003	0.997	0.000
B44.9 Aspergillosis, unspecified	0.003	0.997	0.000
C71.8 Overlapping lesion of brain	0.003	0.997	0.000
J31.2 Chronic pharyngitis	0.003	0.997	0.000
J31 Chronic rhinitis, nasopharyngitis and pharyngitis	0.003	0.997	0.000
C71.3 Parietal lobe	0.003	0.997	0.000
Z63.5 Disruption of family by separation and divorce	0.003	0.997	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.003	0.997	0.000
Q18.0 Sinus, fistula and cyst of branchial cleft	0.000	0.997	0.003
B44 Aspergillosis	0.003	0.997	0.000
C71.0 Cerebrum, except lobes and ventricles	0.003	0.997	0.000
M75.5 Bursitis of shoulder	0.003	0.997	0.000
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.000	0.997	0.003
R52.0 Acute pain	0.003	0.997	0.000
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.000	0.997	0.003
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.997	0.003
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.000	0.997	0.003
Z63.8 Other specified problems related to primary support group	0.003	0.997	0.000
Q18 Other congenital malformations of face and neck	0.000	0.997	0.003
C85.1 B-cell lymphoma, unspecified	0.003	0.997	0.000
N30.3 Trigonitis	0.000	0.997	0.003
C71.6 Cerebellum	0.003	0.997	0.000
J32.8 Other chronic sinusitis	0.003	0.997	0.000
Q12 Congenital lens malformations	0.000	0.997	0.003
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.000	0.997	0.003
V18.2 Unspecified pedal cyclist injured in nontraffic accident	0.000	0.997	0.003
Z63.6 Dependent relative needing care at home	0.003	0.997	0.000
N30.4 Irradiation cystitis	0.000	0.997	0.003
Q12.0 Congenital cataract	0.000	0.997	0.003
M72.28 Plantar fascial fibromatosis-Other	0.003	0.997	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.003	0.997	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.003	0.997	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.003	0.997	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.003	0.997	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.003	0.997	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.003	0.997	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.003	0.997	0.000
C71.4 Occipital lobe	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
H01.0 Blepharitis	0.000	0.997	0.003
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.003	0.997	0.000
C71.7 Brain stem	0.003	0.997	0.000
N30.0 Acute cystitis	0.000	0.997	0.003
Z63.9 Problem related to primary support group, unspecified	0.003	0.997	0.000
Z63.3 Absence of family member	0.003	0.997	0.000
Z63.2 Inadequate family support	0.003	0.997	0.000
Z63.1 Problems in relationship with parents and in-laws	0.003	0.997	0.000
Z63.0 Problems in relationship with spouse or partner	0.003	0.997	0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.003	0.997	0.000
Q43.8 Other specified congenital malformations of intestine	0.000	0.997	0.003
M72.29 Plantar fascial fibromatosis-Site unspec	0.002	0.997	0.000
J32.4 Chronic pansinusitis	0.003	0.997	0.000
Z63.7 Other stressful life events affecting family and household	0.003	0.997	0.000
I60 Subarachnoid haemorrhage	0.003	0.997	0.000
C71.2 Temporal lobe	0.003	0.997	0.000
J31.1 Chronic nasopharyngitis	0.003	0.997	0.000
N30.1 Interstitial cystitis (chronic)	0.000	0.997	0.003
I38 Endocarditis, valve unspecified	0.003	0.997	0.000
Q11 Anophthalmos, microphthalmos and macrophthalmos	0.000	0.997	0.003
C71.5 Cerebral ventricle	0.002	0.997	0.000
K51.2 Ulcerative (chronic) proctitis	0.003	0.997	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.000	0.997	0.003
H43.8 Other disorders of vitreous body	0.000	0.997	0.003
I08.3 Combined disorders of mitral, aortic and tricuspid valves	0.003	0.997	0.000
C71.1 Frontal lobe	0.003	0.997	0.000
Q65.8 Other congenital deformities of hip	0.000	0.997	0.003
Q20-Q28 Congenital malformations of the circulatory system	0.000	0.997	0.003
H43 Disorders of vitreous body	0.000	0.997	0.003
S02.00 Fracture of vault of skull (closed)	0.000	0.997	0.003
K91.0 Vomiting following gastro-intestinal surgery	0.000	0.997	0.003
Q14 Congenital malformations of posterior segment of eye	0.000	0.997	0.002
B44.8 Other forms of aspergillosis	0.002	0.997	0.000
B44.7 Disseminated aspergillosis	0.002	0.997	0.000
B44.2 Tonsillar aspergillosis	0.002	0.997	0.000
B44.0 Invasive pulmonary aspergillosis	0.002	0.997	0.000
H43.2 Crystalline deposits in vitreous body	0.000	0.997	0.002
Q16 Congenital malformations of ear causing impairment of hearing	0.000	0.997	0.002
Q43 Other congenital malformations of intestine	0.000	0.997	0.002
Q13 Congenital malformations of anterior segment of eye	0.000	0.997	0.002
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Q18.9 Congenital malformation of face and neck, unspecified	0.000	0.998	0.002
Q18.8 Other specified congenital malformations of face and neck	0.000	0.998	0.002
Q18.7 Microcheilia	0.000	0.998	0.002
Q18.6 Macrocheilia	0.000	0.998	0.002
Q18.5 Microstomia	0.000	0.998	0.002
Q18.4 Macrostomia	0.000	0.998	0.002
Q18.3 Webbing of neck	0.000	0.998	0.002
Q18.2 Other branchial cleft malformations	0.000	0.998	0.002
Q28 Other congenital malformations of circulatory system	0.000	0.998	0.002
Q24 Other congenital malformations of heart	0.000	0.998	0.002
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.000	0.998	0.002
Q12.9 Congenital lens malformation, unspecified	0.000	0.998	0.002
Q12.8 Other congenital lens malformations	0.000	0.998	0.002
Q12.4 Spherophakia	0.000	0.998	0.002
Q12.3 Congenital aphakia	0.000	0.998	0.002
Q12.2 Coloboma of lens	0.000	0.998	0.002
Q12.1 Congenital displaced lens	0.000	0.998	0.002
Q24.8 Other specified congenital malformations of heart	0.000	0.998	0.002
Q30-Q34 Congenital malformations of the respiratory system	0.000	0.998	0.002
D33.3 Cranial nerves	0.002	0.998	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.000	0.998	0.002
Q11.1 Other anophthalmos	0.000	0.998	0.002
Q21.3 Tetralogy of Fallot	0.000	0.998	0.002
Q10 Congenital malformations of eyelid, lachrymal apparatus and orbit	0.000	0.998	0.002
Q38-Q45 Other congenital malformations of the digestive system	0.000	0.998	0.002
Q35-Q37 Cleft lip and cleft palate	0.000	0.998	0.002
N30.2 Other chronic cystitis	0.000	0.998	0.002
Q15 Other congenital malformations of eye	0.000	0.998	0.002
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.000	0.998	0.002
I08.2 Disorders of both aortic and tricuspid valves	0.002	0.998	0.000
I08 Multiple valve diseases	0.002	0.998	0.000
Q43.9 Congenital malformation of intestine, unspecified	0.000	0.998	0.002
E66.2 Extreme obesity with alveolar hypoventilation	0.002	0.998	0.000
I08.0 Disorders of both mitral and aortic valves	0.002	0.998	0.000
Q28.0 Arteriovenous malformation of precerebral vessels	0.000	0.998	0.002
M23.81 Other internal derangements of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.998	0.002
Q18.1 Preauricular sinus and cyst	0.000	0.998	0.002
Z64.0 Problems related to unwanted pregnancy	0.002	0.998	0.000
E66 Obesity	0.002	0.998	0.000
Z61 Problems related to negative life events in childhood	0.002	0.998	0.000
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.002	0.998	0.000
Q17 Other congenital malformations of ear	0.000	0.998	0.002
Q21 Congenital malformations of cardiac septa	0.000	0.998	0.002
H43.0 Vitreous prolapse	0.000	0.998	0.002
Z64 Problems related to certain psychosocial circumstances	0.002	0.998	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.002	0.998	0.000
Q50-Q56 Congenital malformations of genital organs	0.000	0.998	0.002
I60.5 Subarachnoid haemorrhage from vertebral artery	0.002	0.998	0.000
Q11.3 Macrophthalmos	0.000	0.998	0.002
Q11.2 Microphthalmos	0.000	0.998	0.002
Q11.0 Cystic eyeball	0.000	0.998	0.002
G37.9 Demyelinating disease of central nervous system, unspecified	0.000	0.998	0.002
Q14.1 Congenital malformation of retina	0.000	0.998	0.002
Q43.1 Hirschsprung's disease	0.000	0.998	0.002
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.002	0.998	0.000
Q25 Congenital malformations of great arteries	0.000	0.998	0.002
Q00-Q07 Congenital malformations of the nervous system	0.000	0.998	0.002
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.002	0.998	0.000
Q65 Congenital deformities of hip	0.000	0.998	0.002
S14.1 Other and unspecified injuries of cervical spinal cord	0.002	0.998	0.000
Z61.6 Problems related to alleged physical abuse of child	0.002	0.998	0.000
I60.8 Other subarachnoid haemorrhage	0.002	0.998	0.000
Q28.3 Other malformations of cerebral vessels	0.000	0.998	0.002
Q20 Congenital malformations of cardiac chambers and connexions	0.000	0.998	0.002
I08.1 Disorders of both mitral and tricuspid valves	0.002	0.998	0.000
J32.2 Chronic ethmoidal sinusitis	0.002	0.998	0.000
Q14.9 Congenital malformation of posterior segment of eye, unspecified	0.000	0.998	0.002
Q14.8 Other congenital malformations of posterior segment of eye	0.000	0.998	0.002
Q14.3 Congenital malformation of choroid	0.000	0.998	0.002
Q14.2 Congenital malformation of optic disk	0.000	0.998	0.002
Q14.0 Congenital malformation of vitreous humour	0.000	0.998	0.002
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.998	0.002
Z97.5 Presence of (intra-uterine) contraceptive device	0.002	0.998	0.000
Q26 Congenital malformations of great veins	0.000	0.998	0.002
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.002	0.998	0.000
C84.5 Other and unspecified T-cell lymphomas	0.002	0.998	0.000
H44.2 Degenerative myopia	0.000	0.998	0.002
Q16.9 Congenital malformation of ear causing impairment of hearing, unspecified	0.000	0.998	0.002
Q43.7 Persistent cloaca	0.000	0.998	0.002
Q43.6 Congenital fistula of rectum and anus	0.000	0.998	0.002
Q43.5 Ectopic anus	0.000	0.998	0.002
Q43.4 Duplication of intestine	0.000	0.998	0.002
Q43.2 Other congenital functional disorders of colon	0.000	0.998	0.002
Q99 Other chromosome abnormalities, not elsewhere classified	0.000	0.998	0.002
Q13.9 Congenital malformation of anterior segment of eye, unspecified	0.000	0.998	0.002
Q13.8 Other congenital malformations of anterior segment of eye	0.000	0.998	0.002
Q13.5 Blue sclera	0.000	0.998	0.002
Q13.4 Other congenital corneal malformations	0.000	0.998	0.002
Q13.3 Congenital corneal opacity	0.000	0.998	0.002
Q13.2 Other congenital malformations of iris	0.000	0.998	0.002
Q13.1 Absence of iris	0.000	0.998	0.002
Q13.0 Coloboma of iris	0.000	0.998	0.002
Q16.5 Congenital malformation of inner ear	0.000	0.998	0.002
Q16.4 Other congenital malformations of middle ear	0.000	0.998	0.002
Q16.3 Congenital malformation of ear ossicles	0.000	0.998	0.002
Q16.2 Absence of eustachian tube	0.000	0.998	0.002
Q16.1 Congenital absence, atresia and stricture of auditory canal (external)	0.000	0.998	0.002
Q16.0 Congenital absence of (ear) auricle	0.000	0.998	0.002
Q24.4 Congenital subaortic stenosis	0.000	0.998	0.002
Q24.0 Dextrocardia	0.000	0.998	0.002
Z36.9 Antenatal screening, unspecified	0.000	0.998	0.002
Q98 Other sex chromosome abnormalities, male phenotype, not elsewhere classified	0.000	0.998	0.002
I08.9 Multiple valve disease, unspecified	0.002	0.998	0.000
N30.8 Other cystitis	0.000	0.998	0.002
Q25.4 Other congenital malformations of aorta	0.000	0.998	0.002
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.002	0.998	0.000
Q24.3 Pulmonary infundibular stenosis	0.000	0.998	0.002
Q24.2 Cor triatriatum	0.000	0.998	0.002
Q24.1 Levocardia	0.000	0.998	0.002
Q28.9 Congenital malformation of circulatory system, unspecified	0.000	0.998	0.002
Q28.8 Other specified congenital malformations of circulatory system	0.000	0.998	0.002
Q28.1 Other malformations of precerebral vessels	0.000	0.998	0.002
Z57 Occupational exposure to risk-factors	0.002	0.998	0.000
Q97 Other sex chromosome abnormalities, female phenotype, not elsewhere classified	0.000	0.998	0.002
Q95 Balanced rearrangements and structural markers, not elsewhere classified	0.000	0.998	0.002
Q93 Monosomies and deletions from the autosomes, not elsewhere classified	0.000	0.998	0.002
Q92 Other trisomies and partial trisomies of the autosomes, not elsewhere classified	0.000	0.998	0.002
Q91 Edwards' syndrome and Patau's syndrome	0.000	0.998	0.002
Q24.9 Congenital malformation of the heart, unspecified	0.000	0.998	0.002
Q34 Other congenital malformations of respiratory system	0.000	0.998	0.002
Q33 Congenital malformations of lung	0.000	0.998	0.002
Q32 Congenital malformations of trachea and bronchus	0.000	0.998	0.002
Q30 Congenital malformations of nose	0.000	0.998	0.002
Q35 Cleft palate	0.000	0.998	0.002
D37.6 Liver, gallbladder and bile ducts	0.002	0.998	0.000
D37.1 Stomach	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations